AXGN
NASD Axogen, Inc.$36.54 ↑ +0.37 (+1.02%) Trading Up from the previous close of $36.17
- YTD change
- +11.64%
- vs 20-day SMA
- -10.40%
- vs 200-day SMA
- -6.56%
Price ranges
Price & Performance
+1.71 (+4.96%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 35.7% away from all-time highs of $56.85
- AXGN is up 12% since the beginning of the year
- AXGN is up 130% over the past 12 months
- AXGN is down 19% over the past 1 month
- 8% of all AXGN investors are betting against AXGN
AXGN reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +127.9%.
- Previous minute
- +$0.00
- Last hour
- -$0.01
- Last 5 days
- +0.63%
- vs 8-day SMA
- -0.08%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, AcroVal Neurosensory and Motor Testing System, and AxoTouch Two-Point Discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.